Immunology, Protein engineering, Nucleic Acid Drug, Drug Delivery. Research Associate @MayoClinic, Postdoc @StanfordMed, Ph.D. in PharmSci @KyotoU_News
Our work on immune checkpoint in autoimmune vasculitis, GCA, is out now!
Huge thank you to all the amazing collaborators involved from @MdWarrington , @StanfordMed , @MayoClinic & Weyand Lab #GCA#vasculitis
https://t.co/NssKmf3Hvl
Excited to share this work from the Garcia Lab out today in @NatureComms! We engineer "cytokine adaptors", molecular switches that simultaneously block a target cytokine while inducing local activation of alternative cytokine receptors. https://t.co/CYQzioKFmo
I’m very excited to have received a #K99/R00 award from NIA - on my first try! My program focuses on immune aging and T cell dysfunction, in the context of aging and cellular senescence.
Send exciting opportunities my way - will go faculty job hunting next year!
young adults (<40 years), EBV-specific CD8+ T cells assume preferred differentiation states depending on their peptide specificity. By age >65- years, different T cell specificities had undergone largely distinct aging trajectories https://t.co/VnLPgDR4kh
Excited to share our latest article on Subclinical Aortic Inflammation in Patients with PMR in @RheumJnl 🧿
✅ Persistent aortic inflammation contributes to the development of aortic aneurysms not only in GCA but also in patients with PMR!
https://t.co/evCk06ujyO
#Vasculitis
有り難いことにIUPAB (International Union for Pure and Applied Biophysics) から賞を頂けることになりました。
自分達の研究が国際的組織から評価して頂けたというのは素直に嬉しいです。
6/24より始まるIUPAB2024でlectureをすることにもなったので、学会に参加される&お時間のある方はぜひ。
I would like to share my wonderful and enjoyable three-year journey in Dr. Jorg Goronzy and Dr. Cornelia Weyand's lab at @MayoClinic. This period has been profoundly enriching, both personally and professionally.
In my new journey I am excited joining @UCSF in @diazlaboratory.
PREX1 improves homeostatic proliferation to maintain a naive CD4+ T cell compartment in older age: https://t.co/UVt7zzjgxH
@MayoClinic#Aging#Immunology
I am thrilled to share our first co-author article with Huimin & Hiro from Goronzy Lab
PREX1 improves homeostatic proliferation to maintain a naïve CD4 T cell compartment in #older age published in @JCI_insight
https://t.co/ktZOBeossX
Special shoutout for the whole team 📚🎉
We have an open post-doc position! Our projects include mechanisms of peripheral immune suppression as a result of brain insults. Other projects include responses of tissue resident memory cells in various organs.
Check out this job at Duke University: https://t.co/4kbyY87TWx
My co-first author work has been published in Cell Stem Cell!
https://t.co/TUnO5EAsFC
We modeled episodes of endotheliopathy, thrombosis, and inflammatory responses in COVID-19 by newly developed iPSC-derived human vascular organoid and reconstructed engineered vessels.
#ACR2023@ACRheum is well under way in San Diego! ☀️ Presenting a talk on our giant cell arteritis proteomics research with #MayoClinicRheumatology colleague and friend @MdWarrington at the #Vasculitis session Wed 11/15 11am Room 33A-C. If around, please stop by to say hello 😀👋
Master and apprentice, side by side at #ACR23! Come check out our posters 0268 and 0269 on CT-guided biopsies for retroperitoneal fibrosis and AKI in VEXAS! #MayoClinic#Rheumatology
Sunday afternoon at #ACR23: The Klemperer Memorial Lecture will focus on RA as a mitochondrial disease. Preview the session in ACR Convergence Today → https://t.co/MtT5Ae67MF
Waipan Chan, Ronald Germain et al. @NIAIDNews show that PD-1 engagement by T cells inhibits distinct antigen-evoked signals in a nonlinear manner, strongly influenced by the nature of available TCR ligands. https://t.co/87qnxmZmjt
#TumorImmunology#LymphocyteBiology